Clinical Trials Browser

Phase 2 × Has results × tasquinimod × Clear all

NCT02159950 2023-04-27

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Completed

2 enrolled 7 charts

Prostatic Neoplasms

NCT01732549 2019-11-22

A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy

Phase 2 Terminated

144 enrolled 22 charts

Metastatic Castrate Resistant Prostate Cancer